Company intelligence / Profile preview

Dover Life Sciences

Frederica, Delaware, United States

Ownership: Private
Employees: ~2000
Development stage: Other

Overview

ILC Dover is a leading provider of single-use systems and flexible containment solutions for biopharmaceutical manufacturing and other life science applications. Acquired by Ingersoll Rand in 2024, it supports customers from research to commercial production, leveraging over 25 years in bioprocessing solutions.

Industry: Chemicals & Materials

Beyond the preview

Go deeper on Dover Life Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dover Life Sciences.

Explore the full profile